Skip to main content

New story in Health from Time: Only About Half of Americans Would Get a COVID-19 Vaccine, Poll Finds



Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, according to a new poll from The Associated Press-NORC Center for Public Affairs Research.

That’s surprisingly low considering the effort going into the global race for a vaccine against the coronavirus that has sparked a pandemic since first emerging from China late last year. But more people might eventually roll up their sleeves: The poll, released Wednesday, found 31% simply weren’t sure if they’d get vaccinated. Another 1 in 5 said they’d refuse.

Health experts already worry about the whiplash if vaccine promises like President Donald Trump’s goal of a 300 million-dose stockpile by January fail. Only time and science will tell — and the new poll shows the public is indeed skeptical.

“It’s always better to under-promise and over-deliver,” said Dr. William Schaffner, an infectious disease specialist at Vanderbilt University Medical Center.

“The unexpected looms large and that’s why I think for any of these vaccines, we’re going to need a large safety database to provide the reassurance,” he added.

Among Americans who say they wouldn’t get vaccinated, 7 in 10 worry about safety.

“I am not an anti-vaxxer,” said Melanie Dries, 56, of Colorado Springs, Colorado. But, “to get a COVID-19 vaccine within a year or two … causes me to fear that it won’t be widely tested as to side effects.”

Dr. Francis Collins, who directs the National Institutes of Health, insists safety is the top priority. The NIH is creating a master plan for testing the leading COVID-19 vaccine candidates in tens of thousands of people, to prove if they really work and also if they’re safe.

“I would not want people to think that we’re cutting corners because that would be a big mistake. I think this is an effort to try to achieve efficiencies, but not to sacrifice rigor,” Collins told the AP earlier this month.

“Definitely the worst thing that could happen is if we rush through a vaccine that turns out to have significant side effects,” Collins added.

Among those who want a vaccine, the AP-NORC poll found protecting themselves, their family and the community are the top reasons.

“I’m definitely going to get it,” said Brandon Grimes, 35, of Austin, Texas. “As a father who takes care of his family, I think … it’s important for me to get vaccinated as soon as it’s available to better protect my family.”

And about 7 in 10 of those who would get vaccinated say life won’t go back to normal without a vaccine. A site foreman for his family’s construction business, Grimes travels from house to house interacting with different crews, and said some of his coworkers also are looking forward to vaccination to minimize on-the-job risk.

The new coronavirus is most dangerous to older adults and people of any age who have chronic health problems such as diabetes or heart disease. The poll found 67% of people 60 and older say they’d get vaccinated, compared with 40% who are younger.

And death counts suggest black and Hispanic Americans are more vulnerable to COVID-19, because of unequal access to health care and other factors. Yet the poll found just 25% of African Americans and 37% of Hispanics would get a vaccine compared to 56% of whites.

Among people who don’t want a vaccine, about 4 in 10 say they’re concerned about catching COVID-19 from the shot. But most of the leading vaccine candidates don’t contain the coronavirus itself, meaning they can’t cause infection.

And 3 in 10 who don’t want a vaccine don’t fear getting seriously ill from the coronavirus.

Over 5.5 million people worldwide have been confirmed infected by the virus, and more than 340,000 deaths have been recorded, including nearly 100,000 in the U.S., according to a tally kept by Johns Hopkins University. Experts believe the true toll is significantly higher.

And while most people who get COVID-19 have mild cases and recover, doctors still are discovering the coronavirus attacks in far sneakier ways than just causing pneumonia — from blood clots to heart and kidney damage to the latest scare, a life-threatening inflammatory reaction in children.

Whatever the final statistics show about how often it kills, health specialists agree the new coronavirus appears deadlier than the typical flu. Yet the survey suggests a vaccine would be no more popular than the yearly flu shot.

Worldwide, about a dozen COVID-19 vaccine candidates are in early stages of testing or poised to begin. British researchers are opening one of the biggest studies so far, to test an Oxford University-created shot in 10,000 people.

For all the promises of the Trump administration’s “ Operation Warp Speed,” only 20% of Americans expect any vaccine to be available to the public by year’s end, the poll found. Most think sometime next year is more likely.

Political divisions seen over how the country reopens the economy are reflected in desire for a vaccine, too. More than half of Democrats call a vaccine necessary for reopening, compared to about a third of Republicans. While 62% of Democrats would get the vaccine, only 43% of Republicans say the same.

“There’s still a large amount of uncertainty around taking the vaccine,” said Caitlin Oppenheimer, who leads NORC’s public health research. “There is a lot of opportunity to communicate with Americans about the value and the safety of a vaccine.”

Popular posts from this blog

New story in Health from Time: Here’s How Quickly Coronavirus Is Spreading in Your State

The novel coronavirus pandemic is a global crisis, a national emergency and a local nightmare. But while a great deal of the focus in the U.S. has been on the federal government’s response, widely criticized as slow and halting , the picture on the ground remains very different in different parts of the country. A TIME analysis of the per capita spread of the epidemic in all 50 states and Washington, D.C. found considerable range in the rate of contagion, and, in some parts of the country, a significant disparity compared to the national figure. The U.S., unlike nations such as South Korea and now Italy , has yet to show signs of bringing the runaway spread of the virus under control. However, while no single state is yet showing strong signs of bending the curve , some are faring much worse than others. The following graphic plots the rise in the total confirmed cases of COVID-19 per 100,000 residents in each state, plotted by the day that each state reported its first case.

New story in Health from Time: We Need to Take Care of the Growing Number of Long-term COVID-19 Patients

On July 7, 2020, the Boston Red Sox pitcher Eduardo Rodriguez tested positive for the new coronavirus. He was scheduled to start Opening Day for the Sox, but the virus had other plans— damaging Rodriguez’s heart and causing a condition called myocarditis (inflammation of the heart muscle). Now the previously fit 27-year old ace left-hander must sit out the 2020 season to recover. Rodriguez is not alone in having heart damage from SARS-CoV-2, the virus that causes COVID-19. In a new study done in Germany, researchers studied the hearts of 100 patients who had recently recovered from COVID-19. The findings were alarming: 78 patients had heart abnormalities, as shown by a special kind of imaging test that shows the heart’s structure (a cardiac MRI), and 60 had myocarditis. These patients were mostly young and previously healthy . Several had just returned from ski trips. While other studies have shown a lower rate of heart problems—for example, a study of 416 patients hosp

New story in Health from Time: What We Don’t Know About COVID-19 Can Hurt Us

Countries around the world have introduced stringent control measures to stop COVID-19 outbreaks growing, but now many find themselves facing the same situation again. From Melbourne to Miami, the relaxation of measures had led to increasing flare-ups, which in some places has already meant reclosing schools, businesses or travel routes. Within the U.S. and among different countries , places with wildly varying public-health policies have experienced wildly diverse outcomes. Most ominously, infections are rising rapidly in many places where they once were falling. So how do countries avoid an indefinite, unsustainable, cycle of opening and closing society? What is needed to prevent a future of strict social distancing and closed borders? To escape this limbo, we need to know more about each step in the chain of infection: why some people are more susceptible or have more symptoms, how our interactions and surroundings influence risk, and how we can curb the impact of the re